FR2134810A5 - Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity - Google Patents

Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity

Info

Publication number
FR2134810A5
FR2134810A5 FR7114113A FR7114113A FR2134810A5 FR 2134810 A5 FR2134810 A5 FR 2134810A5 FR 7114113 A FR7114113 A FR 7114113A FR 7114113 A FR7114113 A FR 7114113A FR 2134810 A5 FR2134810 A5 FR 2134810A5
Authority
FR
France
Prior art keywords
alkyl
hypocholesterolaemic
thiazole
bis
alcanes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7114113A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7114113A priority Critical patent/FR2134810A5/en
Application granted granted Critical
Publication of FR2134810A5 publication Critical patent/FR2134810A5/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Abstract

Title cpds. are of formula: (where R1 is H or alkyl; R2 is Me or Et; R3 is t-butyl or t-pentyl and R4 is alkyl) and they are hypocholesterolaemic and hypolipaemic agents. The cpds. are prepd. by acylation of bis-(4-hydroxyphenylthio)alkanes with thiazole-5-carboxylic acid halides or anhydrides.
FR7114113A 1971-04-21 1971-04-21 Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity Expired FR2134810A5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7114113A FR2134810A5 (en) 1971-04-21 1971-04-21 Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7114113A FR2134810A5 (en) 1971-04-21 1971-04-21 Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity

Publications (1)

Publication Number Publication Date
FR2134810A5 true FR2134810A5 (en) 1972-12-08

Family

ID=9075661

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7114113A Expired FR2134810A5 (en) 1971-04-21 1971-04-21 Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity

Country Status (1)

Country Link
FR (1) FR2134810A5 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121319A (en) * 1997-05-14 2000-09-19 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6881860B2 (en) 2000-04-11 2005-04-19 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US6960683B2 (en) 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7071158B2 (en) 1997-07-01 2006-07-04 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US7271274B2 (en) 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US7273948B2 (en) 2003-01-13 2007-09-25 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7294737B2 (en) 2004-04-20 2007-11-13 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
WO2008118948A1 (en) 2007-03-26 2008-10-02 Atherogenics, Inc. Methods and compositions of derivatives of probucol for the treatment of diabetes
US7687659B2 (en) 2005-04-21 2010-03-30 Salutria Pharmaceuticals Llc Process for the separation of probucol derivatives
US7897776B2 (en) 2007-04-23 2011-03-01 Salutria Pharmaceuticals Llc Sulfonamide containing compounds for treatment of inflammatory disorders

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375252B2 (en) 1997-05-14 2008-05-20 Atherogenics, Inc. Compounds and method for the inhibition of the expression of VCAM-1
US7189870B2 (en) 1997-05-14 2007-03-13 Atherogenic, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6548699B1 (en) 1997-05-14 2003-04-15 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6602914B2 (en) 1997-05-14 2003-08-05 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6617352B2 (en) 1997-05-14 2003-09-09 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6828447B2 (en) 1997-05-14 2004-12-07 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6147250A (en) * 1997-05-14 2000-11-14 Atherogenics, Inc. Compounds and methods for the inhibition of the expression of VCAM-1
US6121319A (en) * 1997-05-14 2000-09-19 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US7087645B2 (en) 1997-05-14 2006-08-08 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US7071158B2 (en) 1997-07-01 2006-07-04 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6881860B2 (en) 2000-04-11 2005-04-19 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US7183317B2 (en) 2000-04-11 2007-02-27 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
US6960683B2 (en) 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7371895B2 (en) 2002-07-12 2008-05-13 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US7622604B2 (en) 2003-01-13 2009-11-24 Salutria Pharmaceuticals Llc Process of preparing esters and ethers of probucol and derivatives thereof
US7273948B2 (en) 2003-01-13 2007-09-25 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7294737B2 (en) 2004-04-20 2007-11-13 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
US7271274B2 (en) 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US7687659B2 (en) 2005-04-21 2010-03-30 Salutria Pharmaceuticals Llc Process for the separation of probucol derivatives
WO2008118948A1 (en) 2007-03-26 2008-10-02 Atherogenics, Inc. Methods and compositions of derivatives of probucol for the treatment of diabetes
US8252840B2 (en) 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
US7897776B2 (en) 2007-04-23 2011-03-01 Salutria Pharmaceuticals Llc Sulfonamide containing compounds for treatment of inflammatory disorders

Similar Documents

Publication Publication Date Title
FR2134810A5 (en) Bis-(3-alkyl-5-t-alkyl-4-(thiazole-5-carboxy)phenylthio) alcanes - - with hypocholesterolaemic and hypolipaemic activity
FR2191556A5 (en) N-Acylampicillins - with broad-spectrum antibacterial activity prepd. by acylation with naphthyridine carboxylic acids
GB1059995A (en) Preparation of alkyl 3-chloro-3-arylimino-propionates and tautomers thereof
ES405994A1 (en) Cephalosporins
FR2170496A5 (en) 7-Acylamino-3-substd.-3-cephem-4-carboxylic acids prepn. - from corresp. 7-(5-acylaminoadipamido) derivs
ES402670A1 (en) P-chlorobenzamidoacetohydroxamic acid
FR2275455A1 (en) D-Hydroxyalkyl desoxyvincaminates - by hydrogenation of 2-oxoalkyl desoxyvincaminates and the corresp. apovincaminates (NO190176)
FR2255895A1 (en) Substd. benzo(b,d)pyrans - as anxiolytic, antidepressive and antipsychotic agents
NO137587C (en) PROCEDURE FOR THE PRODUCTION OF SULFUR ACID
SE7408053L (en)
GB1428390A (en) Thiazolidinones
ES423024A1 (en) Novel acid compounds
FR2148056A1 (en) Thiazole-2,4-dimethanol dicarbamates - with circulator and cns activity
SU577207A1 (en) Antifungal-and antibacterial-active substance
HK11477A (en) Alkyl sulfonic acid esters of 1,3,2-oxazaphosphacyclic compounds
FR2056340A5 (en) New phosphonic acid esters
FR2181506A1 (en) Penicillin amides - with improved resistance to penicillinase
FR2271214A1 (en) 7-(N-cyano-imidoylamino)-ceph-3-em-4-carboxylate esters - with antibacterial activity prepd. from N-cyanoimidates and 7-amino-cephem cpds
FR2123206A1 (en) Thiazolyl-pyrrolidinones - as analgesics, sedatives barbiturate-potentiators
GB1365201A (en) 2 4 thiazoledimethanol carbamates and 2 4-thiazoledimethanol
NL7001890A (en) N-substd azetidin-3-sulphonates-sedatives - and inters for guanidino-azetidines
ES405081A1 (en) Derivatives of dibenzodioxepine
FR2146978A1 (en) 5-phenyl thiazol-2-yl thioacetic acids and derivs - with antiinflammatory, analgesic and antipyretic activity
FR2217009A1 (en) 2-Tetrazole analogs of prostaglandins - with bronchodilatory, antihyperten-sive and gastric secretion inhibiting activity
SE386668B (en) PROCEDURE FOR THE PREPARATION OF THIODIPROPIONIC ACID DERIVATIVES

Legal Events

Date Code Title Description
ST Notification of lapse